| Retargeting of T lymphocytes to PSCA-or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR” A Feldmann, C Arndt, R Bergmann, S Loff, M Cartellieri, D Bachmann, ... Oncotarget 8 (19), 31368, 2017 | 111 | 2017 |
| Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy R Aliperta, PB Welzel, R Bergmann, U Freudenberg, N Berndt, ... Scientific reports 7 (1), 42855, 2017 | 58 | 2017 |
| Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells D Bachmann, R Aliperta, R Bergmann, A Feldmann, S Koristka, C Arndt, ... Oncotarget 9 (7), 7487, 2018 | 43 | 2018 |
| Flexible antigen-specific redirection of human regulatory T cells via a novel universal chimeric antigen receptor system S Koristka, M Cartellieri, A Feldmann, C Arndt, S Loff, I Michalk, R Aliperta, ... Blood 124 (21), 3494, 2014 | 43 | 2014 |
| Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts R Aliperta, M Cartellieri, A Feldmann, C Arndt, S Koristka, I Michalk, ... Blood Cancer Journal 5 (9), e348-e348, 2015 | 29 | 2015 |
| Systematic investigation of projectile fragmentation using beams of unstable B and C isotopes R Thies, A Heinz, T Adachi, Y Aksyutina, J Alcantara-Núnes, S Altstadt, ... Physical Review C 93 (5), 054601, 2016 | 14 | 2016 |
| Retargeting of T lymphocytes to PSCA-or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “Unificar”. Oncotarget. 2017 … A Feldmann, C Arndt, R Bergmann, S Loff, M Cartellieri, D Bachmann, ... | 9 | |
| Enhancing the efficacy and specificity of antibody-based T cell retargeting strategies against hematological malignancies C Arndt, M Cartellieri, R Aliperta, S Koristka, I Michalk, M Bornhäuser, ... Blood 122 (21), 930, 2013 | 5 | 2013 |
| Development of a bispecific antibody-releasing stem cell system for the eradication of acute myeloid leukemia blasts via redirected immune effector cells R Aliperta, M Cartellieri, A Feldmann, C Arndt, S Koristka, I Michalk, ... Blood 124 (21), 4810, 2014 | 2 | 2014 |
| Human stem cell humanized mouse model for in vivo evaluation of bispecific antibody efficacy and drug-induced cytokine release LC Yao, D Cai, R Aliperta, A Colthart, W Meier, M Cheng, JG Keck Cancer Research 80 (16_Supplement), 5186-5186, 2020 | | 2020 |
| Preclinical evaluation of efficacy and cytokine release of bispecific T cell engagers in humanized NSG mice LC Yao, D Cai, R Aliperta, A Colthart, W Meier, M Cheng, JG Keck The Journal of Immunology 204 (1_Supplement), 91.1-91.1, 2020 | | 2020 |
| Development of a Bispecific Antibody-based System for AML Immunotherapy R Aliperta Technische Universität Dresden, Medizinische Fakultät, 2016 | | 2016 |
| Cryogels to establish immunotherapeutic organoids R Aliperta, P Welzel, M Stanzione, M Cartellieri, U Freudenberg, C Arndt, ... | | |
